Lens Technology (06613) plans to acquire a 59.7805% stake in PMG International for US$25 million.
Lens Technology (06613) announced that on October 16, 2026, the company (the buyer) signed a Share Purchase Agreement regarding 59.7805% of the shares of PMG International Co., Ltd. with Mr. Lu Songshou (the seller), PMG International, Yuanshi Technology, and Lu Shaohua, pursuant to which the company conditionally agreed to purchase approximately 2.989 million ordinary shares of PMG International held by Mr. Lu Songshou, representing 59.7805% of the entire issued share capital of PMG International, for a consideration of US$25 million.
Lens Technology (06613) announced that on October 16, 2026, the company (the buyer) signed a Share Purchase Agreement with Mr. Lu Songshou (the seller), PMG International, Yuanshi Technology, and Lu Shaohua regarding the purchase of a 59.7805% stake in PMG International Co., Ltd. The company has conditionally agreed to purchase approximately 2.989 million ordinary shares of PMG International held by Mr. Lu Songshou, representing 59.7805% of PMG International's total issued share capital, for a consideration of US$25 million.
Upon completion of the acquisition, PMG International will become a controlled subsidiary of the company. Accordingly, the financial results of the target group will be consolidated into the company's financial statements.
Currently, the target group has completed the expansion of production for AI server structural components, high-efficiency liquid cooling systems, and other products at the Songshan Lake campus. It has passed factory audits by leading domestic and international customers and obtained formal orders, and is currently in the mass production ramp-up phase.
The acquisition of the remaining 40.2195% equity interest in PMG International, including the transaction amount and transaction structure, will be subject to further negotiation and discussion among the relevant parties based on PMG International's actual operating conditions, audit and valuation results, and will be determined by both parties in a subsequent acquisition agreement. There is a certain degree of uncertainty, and the company will continue to disclose subsequent progress in accordance with regulations.
Related Articles

US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.

US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall

AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.

US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall

AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.






